Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. safety data
Show results for
Products
Services

Companies

News
Articles
Downloads

Refine by
Date

  • This Year
  • Older

Safety Data Articles & Analysis

24 articles found

Advancing Cancer Treatment: The Role of Radioactive Drug Conjugate Development Services and Pre-Clinical Analysis Services for RDCs

Advancing Cancer Treatment: The Role of Radioactive Drug Conjugate Development Services and Pre-Clinical Analysis Services for RDCs

In Vitro and In Vivo Studies: Prior to human trials, extensive laboratory studies are conducted to evaluate the efficacy, stability, and safety of the conjugate. This includes assessing how well the conjugate binds to its target and how effectively it can deliver radiation to kill cancer cells. 4. ...

ByAlfa Cytology


The Importance of Pharmacokinetic and Toxicokinetic Studies in Drug Development

The Importance of Pharmacokinetic and Toxicokinetic Studies in Drug Development

Fundamentally, TK studies provide an understanding of the systemic exposure-risk relation and delivery of safety data for the dose-response analysis. It outlines parameters such as the maximum tolerated dose, no observable adverse effect level, or the lethal dose for a certain percent of the population. ...

ByCreative Bioarray


Analysis of ADC Drug Biological Activity

Analysis of ADC Drug Biological Activity

Pharmacokinetics and Pharmacodynamics (PK/PD) AnalysisStudying the absorption, distribution, metabolism, and excretion characteristics of ADC in the body, as well as the relationship between drug concentration and efficacy, is the basis for understanding its efficacy and safety framework. These data are crucial for designing appropriate administration plans and ...

ByMtoZ Biolabs


The NObreath® Utilising the Partition Method in FeNO Testing

The NObreath® Utilising the Partition Method in FeNO Testing

Available from: https://nj.gov/health/eoh/rtkweb/documents/fs/1578.pdf 4. Safety data sheet potassium permanganate [Internet]. AquaPhoenix Scientific. 2015. ...

ByBedfont Scientific Limited


Surgical Video Data Privacy, Misconceptions & the Benefits of PSO

Surgical Video Data Privacy, Misconceptions & the Benefits of PSO

In recent years, there has been a growing trend of using video technology in surgical procedures to enhance precision, communication, and training. While the benefits of video in surgery are many, there are also concerns regarding the legal risks that may arise from its use. Medical professionals fear that video footage of a surgery could potentially be used against them in legal proceedings, ...

ByCaresyntax


Psychosocial Event Management Tools: A New Approach to Improving Employee Mental Health in the Workplace

Psychosocial Event Management Tools: A New Approach to Improving Employee Mental Health in the Workplace

Mental health is a critical concern for all companies. One in five individuals will experience a mental health problem during their lives, according to the World Health Organization. For many people, the workplace is where mental health problems first begin and/or become exacerbated. ...

ByCINTELLATE EHS & Risk Management Software - SAI Global Limited


Medical Battery Pack - Most Common Applications

Medical Battery Pack - Most Common Applications

Why Do You Need One? A medical battery pack is an essential part of any medical device. It provides power to the device when no other power source is available. This kinf of battery pack can be used on a number of devices, including portable defibrillators, heart monitors and other life-saving devices. There are many different types of medical battery pack manufacturing on the market today. ...

ByTadiran Batteries GmbH


Clinical Pharmacology of Antibody-Drug Conjugates

Clinical Pharmacology of Antibody-Drug Conjugates

ADC Pharmacokinetic Model The application of models can integrate PK, efficacy, and safety data to meet the needs of ADC drug development at different stages, such as target selection, antibody affinity, linker stability, animal-to-human extrapolation, dose selection and adjustment, exposure-response relationships, DDI studies, etc. ...

ByBOC Sciences


Antibody-Drug Conjugates For The Treatment of Prostate Cancer

Antibody-Drug Conjugates For The Treatment of Prostate Cancer

DSTP3086S, a humanized IgG1 anti-steap1 monoclonal antibody related to MMAE, demonstrated safety and significant antitumor activity in a Phase I trial of 77 mCRPC patients. ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Familiar but Mysterious: Understanding Software as a Medical Device

Familiar but Mysterious: Understanding Software as a Medical Device

As technology continues to advance software has become an important part of most products. It has become integrated widely into medical platforms. In 2019, the Software as a Medical Device (SaMD) market was estimated at about $18.4 million, and it is projected to reach $86 million by 2027 at an annual growth rate of 21.9%. As one of the fastest growing sectors in healthcare, we explore when ...

ByBioT Medical


A Phase 1 Study Investigating the Combination of AFM13 and the Monoclonal Anti-PD-1 Antibody Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymphoma after Brentuximab Vedotin Failure: Updated Safety and Efficacy Data

A Phase 1 Study Investigating the Combination of AFM13 and the Monoclonal Anti-PD-1 Antibody Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymphoma after Brentuximab Vedotin Failure: Updated Safety and Efficacy Data

AFM13 showed single agent clinical activity with solid safety profile in a Phase 1 study2. Pre-clinical in vivo data of the combination of AFM13 with PD1-blockade showed synergism and the potential for induction of cross-talk between innate and adaptive immunity.3 Based on these findings, we conducted a Phase 1b study evaluating the safety and ...

ByAffimed GmbH


Essential Clinical Trial Systems for Small, Midsize, and Large Pharma

Essential Clinical Trial Systems for Small, Midsize, and Large Pharma

Revisiting the “why” behind decision making can be a helpful exercise in all aspects of business. This is no less true for clinical operations executives when it comes to the clinical trial systems they employ to facilitate their teams’ work. The technology that supports clinical trial systems has evolved steadily over the past several decades, yet the ultimate goal of ...

BySeascape Clinical


CP101, an Investigational Oral Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection

CP101, an Investigational Oral Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection

Place bo-control led trials assessing microbiome therapeutics have demonstrated efficacy in recurrent CDI; hov/ever, long-term safety and efficacy data from rigorously conducted studies of microbiome therapies, including cumulative efficacy in those who received a second dose following a CDI recurrence, is limited. ...

ByFinch Therapeutics Group, Inc.


Why open-source AI platforms are the future of patient health tracking in clinical trials

Why open-source AI platforms are the future of patient health tracking in clinical trials

This is not only a frustrating experience for patients, but it can also compromise the safety data in a clinical trial. The good news is that we may be able to solve this problem with open-source artificial intelligence (AI) and old-fashioned scientific validation. ...

ByAiCure


Could Probiotics be the Future of Vaginal Health?

Could Probiotics be the Future of Vaginal Health?

While some clinical research has found positive correlations between probiotic supplementation and a reduction in thrush, BV, UTIs, vaginal dryness, or other genital tract issues — larger scale studies, efficacy and safety data are needed to propel the vaginal probiotics space ...

ByJuno Bio


Landmark study confirms that controlled blood pressure is key to prevent stroke, heart disease

Landmark study confirms that controlled blood pressure is key to prevent stroke, heart disease

The NIH ceased randomly assigned treatments in 2015, when data was presented to the Data and Safety Monitoring Board showing treatment to SBP of less than 120 decreased the rate of a composite cardiovascular disease (CVD) outcome by 25 percent and the rate of all-cause death by 27 percent. Researchers reported these findings in 2015, but ...

ByCardiox Corporation


Latest data on the safety and effectiveness of COVID-19 vaccines in children

Latest data on the safety and effectiveness of COVID-19 vaccines in children

Food and Drug Administration for children under emergency use authorization, with others expected to follow soon, many are seeking information on the safety, efficacy, and necessity of COVID-19 vaccines for children, as parents face the critical decision of if and when to vaccinate. This blog answers the most common questions with an in-depth look at the available ...

ByChemical Abstracts Service (CAS)


Early efficacy signals in ovarian cancer patients in ongoing Ph1 trial: Poster reporting findings presented at SITC 2020 Annual Meeting

Early efficacy signals in ovarian cancer patients in ongoing Ph1 trial: Poster reporting findings presented at SITC 2020 Annual Meeting

ENB Therapeutics reports preliminary data from the ongoing Phase 1/2 trial assessing the safety and efficacy of lead product ENB-003 in combination with pembrolizumab. Safety data are encouraging with no significant drug related safety events from the first 3 dosing cohorts. ...

ByENB Therapeutics


Ancora Heart sees positive early results with Accucinch in systolic heart failure

Ancora Heart sees positive early results with Accucinch in systolic heart failure

“Early safety and efficacy data on the transcatheter Accucinch system is impressive and suggests the therapy has the potential to repair the left ventricle, improve heart function, and restore the quality of life for heart failure patients,” said Satya Shreenivas, interventional cardiologist at The Christ Hospital Heart and Vascular Center and The ...

ByAncora Heart, Inc


Ancora Heart Announces Positive Safety and Efficacy Data from Study of First-of-Its-Kind Investigational Heart Failure Therapy

Ancora Heart Announces Positive Safety and Efficacy Data from Study of First-of-Its-Kind Investigational Heart Failure Therapy

The data was presented at the 31st Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation. ...

ByAncora Heart, Inc

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT